STOCK OPTIONS AND WARRANTS (Details 2) |
9 Months Ended |
|---|---|
|
Sep. 30, 2019
shares
| |
| Exercisable at End of Year | 802,967 |
| Exercisable at End of Year | 808,787 |
| Stock Options [Member] | |
| Number of options | 822,797 |
| Weighted average remaining life in years | 6 years 9 months 18 days |
| Exercisable at End of Year | 808,787 |
| 0.01-2.50 [Member] | |
| Number of options | 330,350 |
| Weighted average remaining life in years | 6 years 8 months 12 days |
| Exercisable at End of Year | 330,350 |
| 2.51-5.00 [Member] | |
| Number of options | 35,000 |
| Weighted average remaining life in years | 9 months 18 days |
| Exercisable at End of Year | 35,000 |
| 5.01 And Up [Member] | |
| Number of options | 457,447 |
| Weighted average remaining life in years | 7 years 2 months 12 days |
| Exercisable at End of Year | 443,437 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|